pentobarbital will decrease the level or result of ombitasvir/paritaprevir/ritonavir & dasabuvir (DSC) by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated. Robust CYP3A4 inducers may reduce partiaprevir and ritonavir concentrations, and for that reason diminished efficacy